Skip to main content
SpringerLink
Log in

Regulation of Prostaglandin Synthesis by Biological Response Modifiers and Effect on Natural Killer Cells and Bone Marrow

  • Chapter
Prostaglandins and Immunity

Part of the book series: Prostaglandins, Leukotrienes, and Cancer ((PLAC,volume 4))

  • 36 Accesses

Abstract

Prostaglandins of the E-series (PGE) have been shown to have numerous effects on the cellular components of the immune system (for review see 1). PGE modulates the cytotoxicity of natural killer (NK) cells (2, 3) and also has been suggested to serve as a negative feedback regulator of macrophage-mediated cytotoxicity (4, 5). Immunoglobulin production by B cells is augmented by PGE (6), whereas blastogenesis of T cells after mitogen stimulation and cell-mediated immunity are inhibited by PGE (7, 8, 9). Growth and differentiation of the granulocyte-macrophage-committed stem cell (GM-CFU-C) in the bone marrow appears to be regulated by the antagonistic effects of colony-stimulating factor and PGE (10). Additionally, PGE production by tumor cells has been suggested to be a mechanism by which tumor cells can escape the host’s immune surveillance (11). The major source for PGE in the immune system has been shown to be monocytes and macrophages (Mø) (12). When stimulated with different agents, such as lipopolysaccharide (LPS) and zymosan, mononuclear phagocytes increase their PGE production and release high amounts of PGE (5, 13, 14). Several biological response modifiers (BRMs) have been reported to be Mø activators and some also augment NK cells (for review see 15). A few have also been shown to activate naive macrophages directly in vitro to express a tumoricidal response. Few studies have been conducted to assess whether BRMs, reported to be Mø activators, could alter PGE production.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldyne ME, Stobo JD: Immunoregulatory role of prostaglandin and related lipids. CRC Crit Rev Immunol (2): 189, 1982.

    Google Scholar 

  2. Brunda MJ, Herberman RB, Holden HT: Inhibition of murine natural killer cell activty by prostaglandins. J Immunol (124): 2682, 1980.

    PubMed  CAS  Google Scholar 

  3. Koren HS, Anderson SJ, Fischer DG, Copeland CS, Jensen PJ: Regulation of human natural killing. I. The role of monocytes, interferon and prostaglandins. J Immunol (127): 2007, 1981.

    Google Scholar 

  4. Schultz RM, Stoychkov JN, Pavlidis N, Chirigos MA, Olkowski ZL: Role of E-type prostaglandins in the regulation of interferon-treated macrophage cytotoxic activity. J Reticuloendothel Soc (26): 93, 1979.

    PubMed  CAS  Google Scholar 

  5. Taffet SM, Russell SW: Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J Immunol (126): 424, 1981.

    CAS  Google Scholar 

  6. Wieder KJ, Webb DR: The effect of prostaglandin metabolism on immunoglobulin and antibody production in naive and educated whole spleen cells. Prostaglandin Med (7): 79, 1981.

    Article  CAS  Google Scholar 

  7. Baker PE, Fahey JV, Munck A: Prostaglandin inhibition of T-cell proliferation is mediated at two levels. Cell Immunol (61): 52, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Goodwin JS, Messner RP, Peake GT: Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. J Clin Invest (62): 753, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. Leung KH, Mihich E: Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo generated effector cells. Int J Immunopharmacol (4): 205, 1982.

    Article  PubMed  CAS  Google Scholar 

  10. Pelus LM, Broxmeyer HE, Kurland JI, Moore MAS: Regulation of macrophage and granulocyte proliferation. J Exp Med (150): 277, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Trevisani A, Ferretti E, Capuzzo A, Tomasi V: Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumor growth by non-steroidal anti-inflammatory drugs. Br J Cancer (41): 341, 1980.

    Article  PubMed  CAS  Google Scholar 

  12. Kurland JI, Bockman R: Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med (147): 952, 1978.

    Article  PubMed  CAS  Google Scholar 

  13. Bonney RJ, Wightman PD, Davies P, Sadowski SJ, Kuehl FA, Humes JL: Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. Biochem J (176): 433, 1978.

    PubMed  CAS  Google Scholar 

  14. Wahl LM, Rosenthal DL, Glode LM, Sandberg AL, Mergenhagen SE: Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations. Infect Immun (23): 8, 1979.

    PubMed  CAS  Google Scholar 

  15. Chirigos MA, Mitchell M, Mastrangelo MJ, Krim M: Mediation of Cellular Immuity in Cancer by Immune Modifiers. Raven Press, New York, 1981.

    Google Scholar 

  16. Stevenson HC, Katz P, Wright DG, Contreras TJ, Jemionek JF, Hartwig VM, Flor WJ, Fauci AS: Human blood monocytes: Characterization of negatively selected human monocytes and their suspension cell culture derivatives. Scand J Immunol (14): 1, 1981.

    Article  Google Scholar 

  17. Schlick E, Friedberg KD: Bone marrow cells of mice under the influence of low lead dose. Arch Toxicol (49): 227, 1982.

    Article  PubMed  CAS  Google Scholar 

  18. Steel LK, Kaliner M: Prostaglandin-generating factor of anaphylaxis. J Biol Chem (256): 12692, 1981.

    PubMed  CAS  Google Scholar 

  19. Steel LK, Platshon L, Kaliner M: Prostaglandin generation by human and guinea pig lung tissue. Comparison of parenchymal and airway responses. J Allergy Clin Immunol (64): 387, 1979.

    Article  Google Scholar 

  20. Pelus LM, Broxmeyer HE, DeSousa M, Moore MAS: Heterogeneity among resident murine peritoneal macrophages: Separation and functional characterization of monocytoid cells producing granulocyte-macrophage colony-stimulating (GM-CSF) and responding to regulation by lactoferrin. J Immunol (126): 1016, 1981.

    PubMed  CAS  Google Scholar 

  21. Pelus LM, Broxmeyer HE, Kurland JI, Moore MAS: Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (150): 277, 1979.

    Article  CAS  Google Scholar 

  22. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. Int J Cancer (16): 216, 1975.

    Article  PubMed  CAS  Google Scholar 

  23. Chirigos MA, Mastrangelo MJ: Immunorestoration by chemicals. In: Mihich E (ed) Immunological approaches to cancer therapeutics. John Wiley & Sons, New York, 1982, pp 191–239.

    Google Scholar 

  24. Herberman RB, Brunda MJ, Cannon GB, Djeu JY, Nunn ME, Jett JR, Ortaldo JR, Reynolds C, Riccardi C, Santoni A. In: Hersh EM et al. (eds) Augmenting agents in cancer therapy. Raven Press, New York, 1981, pp 253–265.

    Google Scholar 

  25. Maluish AE, Ortaldo JR, Conlon JC, Sherwin SA, Leavitt R, Strong DM, Weirnik P, Oldham RK, Herberman RB: Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol (131): 503, 1983.

    PubMed  CAS  Google Scholar 

  26. Bruley-Rosset M, Rappaport H: Natural killer cell activity and spontaneous lymphoma development. Effect of single and multiple injections of interferon in young and aged C57BL/6 mice. Int J Cancer (31): 381, 1983.

    Article  PubMed  CAS  Google Scholar 

  27. Piccoli M, Saito T, Chirigos MA: Biomodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities. Int J Immunopharmacol, 1984, in press.

    Google Scholar 

  28. Bartocci A, Papademetriou V, Chirigos MA: Enhanced macrophage and natural killer cell antitumor activity by various molecular weight maleic anydride divinyl ethers. J Immunopharmacol (2): 49, 1980.

    Article  Google Scholar 

  29. Yaron M, Yaron I, Wiletzki C, Zor U: Interrelationship between stimulation of prostaglandin E and hyaluronate production by poly (I) poly (C) and interferon in synovial fibroblast culture. Arthritis Rheum (21): 694, 1978.

    Article  PubMed  CAS  Google Scholar 

  30. Lee SH, Epstein LB: Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol (50): 177, 1980.

    Article  PubMed  CAS  Google Scholar 

  31. Verma DS, Spitzer G, Zander AR, Gutterman JV, McCredie KB, Dicke KA, Johnston DA: Human leukocyte interferon preparation-mediated block of granulopoietic differentiation in vitro. Exp Hematol (9): 63, 1981.

    PubMed  CAS  Google Scholar 

  32. Tracey DE, Adkinson, Jr. NF: Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity. J Immunol (125): 136, 1980.

    PubMed  CAS  Google Scholar 

  33. Schultz RM, Papamatheakis JD, Chirigos MA. In: Chirigos MA (ed) Immune modulation and control of neoplasia by adjuvant therapy. Raven Press, New York, 1978, pp 459.

    Google Scholar 

  34. Schultz RM, Pavlidis NA, Stylos WA, Chirigos MA: Regulation of macrophage tumoricidal function: A role for prostaglandins of the E series. Science (202): 320, 1978.

    CAS  Google Scholar 

  35. Schultz RM, Jackson WT. In: Chirigos MA, Mitchell M, Mastrangelo MJ, Krim M (eds) Mediation of cellular immunity in cancer by immune modifiers. Raven Press, New York, 1981, pp 89.

    Google Scholar 

  36. Shaw JO, Russell SW, Printz MP, Skidgel RA: Macrophage-mediated tumor cell killing: A lack of dependence on the cyclooxygenase pathway of prostaglandin synthesis. J Immunol (123): 50, 1979.

    PubMed  CAS  Google Scholar 

  37. Kurland JI, Hadden JW, Moore MAS: Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells. Cancer Res (37): 4534, 1977.

    PubMed  CAS  Google Scholar 

  38. Jaffee BM, Behrman HR, Parker CW: Radioimmunoassay measurement of prostaglandin E, A and F in human plasma. J Clin Invest (52): 398, 1973.

    Article  Google Scholar 

  39. Berenbaum MC, Cope WA, Bundick RV: Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Clin Exp Immunol (26): 534, 1976.

    PubMed  CAS  Google Scholar 

  40. Henney CS, Tracey DE, Durdik JM, Klimpel G: Natural killer cells: In vitro and in vivo. Am J Path (93): 459, 1978.

    PubMed  CAS  Google Scholar 

  41. Roder JC, Klein M: Target-effector interactions in the natural killer cell system. II. Modulation by cyclic nucleotides. J Immunol (123): 2785, 1979.

    PubMed  CAS  Google Scholar 

  42. Droller MJ, Schneider MV, Pearlmann P: A possible role for prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol (39): 165, 1978.

    Article  PubMed  CAS  Google Scholar 

  43. Tracey DE, Davis JW, Taggart MT, Silberman SL: Modulation of natural killer cell activity by interferons and prostaglandins. Afr J Clin Exp Immunol (3): 19, 1982.

    CAS  Google Scholar 

  44. Unanue ER: The regulation of lymphocyte functions by the macrophage. Immunol Rev (40): 227, 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael A. Chirigos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erich Schlick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Klaus Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Gerontology, Department of Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA

    J. S. Goodwin

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Chirigos, M.A., Schlick, E., Hartung, K. (1985). Regulation of Prostaglandin Synthesis by Biological Response Modifiers and Effect on Natural Killer Cells and Bone Marrow. In: Goodwin, J.S. (eds) Prostaglandins and Immunity. Prostaglandins, Leukotrienes, and Cancer, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2603-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2603-8_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9630-0

  • Online ISBN: 978-1-4613-2603-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation